KCT0005024
Not Yet Recruiting
N/A
ong-Term Cognitive Prognosis of hearing status
ConditionsDiseases of the nervous system
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Diseases of the nervous system
- Sponsor
- Asan Medical Center
- Enrollment
- 300
- Status
- Not Yet Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Patients who have visited the memory clinic since May 2020\.
- •\- Comprehensive neuropsychologic test and Brain MRI
- •\- Over age 50
Exclusion Criteria
- •In case of following structures which can rapidly deteriorate the cognitive function of patients were confirmed
- •intracranial hemorrhage, sub\-dural hemorrhage, traumatic brain hemorrhage
- •acute cerebral infarction
- •brain neoplasm, brain tumor (malignant/benign)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Prognostic factors of hearing loss and auditoty abnormal sensatiohearing loss, tinnitus, hyperacusisJPRN-UMIN000015613Keio University School of Medicine, Department of Otolaryngology2,000
Completed
N/A
ong-term results for hearing and speech comprehension and hearing-related quality of life in OSIA patientsH90H90.4Conductive and sensorineural hearing lossSensorineural hearing loss, unilateral with unrestricted hearing on the contralateral sideDRKS00024640Abteilung für Hals-, Nasen- und OhrenheilkundeUniversitätsklinikum Freiburg22
Suspended
N/A
Treating auditory impairment and cognition pilot trialMild cognitive impairment and hearing lossNervous System DiseasesMild cognitive disorder, hearing lossISRCTN47591507niversity College London76
Completed
N/A
ongitudinal evaluation of hearing loss and other hearing complaints in professional musiciansHearing impairmentMusic induced hearing loss10019243NL-OMON48954Klinische en Experimentele Audiologie63
Not Yet Recruiting
N/A
analysis on cognition effectiveness of hearing aid and cochlear implant to the patients with hearing lossJPRN-UMIN000020721Japan Agency for Medical Research and Development60